Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Online Tool Helps Validate Clinical Molecular Assays

By LabMedica International staff writers
Posted on 08 Dec 2010
A new online tool helps clinical laboratories standardize their verification and validation requirements and eases adoption of new molecular tests.

The web-based program is designed to assist laboratories in identifying molecular assay verification or validation requirements to comply with clinical laboratory improvement amendments (CLIA) accreditation requirements in the United States and meet International Standards Organization (ISO) standards in Europe. More...
Compliance with CLIA requirements is necessary for any laboratory that reports patient results for clinical purposes in the United States.

The EZValidation Online Tool, which was launched by Life Technologies' (Carlsbad, CA, USA) and configured to work with the company's AcroMetrix quality control materials, helps labs establish an easy-to-use workflow from protocol development through the final report generation. The tool provides a simplified path for adopting new molecular assays through ISO 15189, CLIA, College of American Pathologists (CAP) and New York State guidelines. The online tool is also updateable for new guidelines and tests as they are developed.

Kimberlee Caple, head of Molecular Medicine Products at Life Technologies said, "EZValidation's Online Tool will help clinical labs maintain their compliance and adopt new molecular tests to foster the accuracy, reliability, and timeliness of patients' results." She added, "The clinical laboratory market is the front line for the adoption of molecular medicine in healthcare, and EZValidation helps those facilities incorporate molecular assays more efficiently, accurately and effectively."

Related Links:
Life Technologies



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.